This announcement is a separate document:
天职国际会计师事务所（特殊普通合伙）关于对康美药业2023年度营业收入扣除情况的专项核查意见
Tianji International Accounting Firm (Special General Partnership) Special Inspection Opinions on Kangmei Pharmaceutical's 2023 Operating Income Deduction
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.